Latest 20-F annual reports

NASDAQ
EUDA Health Holdings Limited filed an amended annual report highlighting substantial doubt about its ability to continue as a going concern due to significant losses and an accumulated deficit.
NASDAQ
CDT Environmental Technology Investment Holdings Limited filed an amended annual report for 2024, revealing a significant 80% decrease in net income to $1.4 million, primarily due to reduced demand and increased credit loss provisions.
NYSE
Endava plc reported a 4.3% revenue increase to £772.3 million in fiscal year 2025, but profit before tax significantly declined to £24.1 million amidst macroeconomic challenges and strategic shifts towards AI.
NASDAQ
Jiuzi Holdings Inc. filed an amendment to its annual report, disclosing a significant increase in net loss to $55.77 million for fiscal year 2024, driven by substantial bad debt provisions and stock-based compensation.
OTC.Pink
Cloopen Group Holding Limited reported a significant reduction in net loss for 2024, alongside minimal revenue growth, as it navigates operational challenges and addresses past regulatory issues.
NYSE
Sabesp filed an amendment to its 2024 annual report, significantly reducing its estimated legal claims from R$167.7 billion to R$24.7 billion while adding details on a new, unquantified legal proceeding.
NASDAQ
Mesoblast Limited achieved a significant milestone with FDA approval for Ryoncil, its first mesenchymal stromal cell therapy, and successfully raised $160 million in a private placement, despite ongoing operating losses.
NASDAQ
111, Inc. filed an amendment to its 2024 annual report, showcasing a significant turnaround in operating income and a substantial reduction in net loss, alongside positive operating cash flow.
NYSE
Sasol Limited reports a significant turnaround in earnings for fiscal year 2025, despite substantial asset impairments and ongoing operational challenges, driven by strategic shifts and cost optimization.
NASDAQ
Alterity Therapeutics Limited announced positive topline data from its Phase 2 clinical trials for ATH434 in Multiple System Atrophy, demonstrating significant slowing of disease progression and a favorable safety profile.
Earlyworks Co., Ltd. reported significant revenue growth for fiscal year 2025, driven by software development, but faces substantial doubt about its ability to continue as a going concern and a Nasdaq delisting threat.
Check-Cap Ltd. reported a $25.1 million net loss for 2024, fully impaired $16.5 million in loans to Nobul AI Corp., and faces Nasdaq delisting threats while pursuing a business combination.
NASDAQ
Robot Consulting Co., Ltd. filed an amendment to its annual report to include the auditor's conformed signature and updated certifications, with no other changes to the financial statements.
NASDAQ
Quhuo Limited filed an amendment to its annual report, confirming an auditor change and reporting a significant revenue and profit decline for fiscal year 2024.
NASDAQ
AGM Group Holdings Inc. filed an amendment to its 2024 annual report, clarifying its reliance on British Virgin Islands home country corporate governance practices instead of certain Nasdaq listing rules.
NASDAQ
Locafy Limited has filed an amended annual report, restating its fiscal year 2024 financial statements due to accounting errors related to performance rights, while reporting a reduced net loss and strategic shift towards proprietary publishing solutions.
NYSE
BHP achieved record copper and iron ore production in FY2025, delivering robust financial results and increasing its net debt target to fund future growth, despite cost overruns and delays at its Jansen potash project and the temporary suspension of its Western Australia Nickel operations.
NASDAQ
Intelligent Group Limited filed an amendment to its annual report, revealing material weaknesses in its internal controls over financial reporting and ineffective disclosure controls.
NASDAQ
Real Messenger Corporation filed an amendment to its annual report to include a new Clawback Policy for executive compensation, aligning with SEC and Nasdaq requirements.
NASDAQ
Bluemount Holdings Limited, a Hong Kong-based consulting, financial services, and luxury timepiece trader, reported significant revenue and profit growth for the fiscal year ended March 31, 2025, following its successful Nasdaq IPO.
NASDAQ
Reitar Logtech Holdings Limited reported a significant decline in net income and gross profit margin for fiscal year 2025, despite substantial revenue growth, alongside strategic moves into digital assets and new acquisitions.
NASDAQ
Bluemount Holdings Limited reported a significant revenue and profit increase in fiscal year 2025, driven by robust luxury timepiece trading, following its successful Nasdaq IPO.
NASDAQ
Ming Shing Group Holdings Limited reported a significant net loss for the fiscal year ended March 31, 2025, driven by increased costs and unfinalized project variations, despite revenue growth.
NASDAQ
Kyivstar Group Ltd. announces the successful completion of its business combination, becoming the direct parent of Ukraine's leading telecom provider.
NASDAQ
K-Tech Solutions reports an 8.7% revenue increase for fiscal year 2025, but net income fell by 47.4%, impacted by higher operating expenses and a decrease in other income.
ALE Group Holding Limited reported an 8.7% increase in total revenue and an 18.7% rise in net income for the fiscal year ended March 31, 2025, while highlighting significant operational and regulatory risks.
NASDAQ
Lianhe Sowell International Group Ltd reported a net income increase to $3.18 million for fiscal year 2025, driven by a significant surge in software revenue despite a slight overall revenue dip, as it progresses with its Nine-Axis Linkage Spray Painting Robot production plan.
NASDAQ
Robot Consulting Co., Ltd. reported continued operating losses and an accumulated deficit, raising substantial doubt about its ability to continue as a going concern, despite a recent IPO and growth in its Labor Robot user base.
CTRL Group Limited reported a substantial net loss of HK$26.8 million for the fiscal year ended March 31, 2025, driven by decreased advertising revenue and significant impairment losses on new exhibition and game development ventures.
NASDAQ
Akso Health Group reported a significant net loss of $135.5 million for fiscal year 2025, driven by substantial impairment charges on acquired assets and ongoing operational challenges.